Provider records sourced from NPPES (CMS National Plan & Provider Enumeration System). Data current as of August 10, 2026.

Mayank Shukla

Individual provider Sleep Medicine (Internal Medicine) Physician · NPI 1356403042

Mayank Shukla is registered under Pulmonary Disease in New York, New York. Qualified in 1995, 31 years ago. Accepts Medicare assignment. Licensed in New York.

Years since qualifying
31
Licensed in
NY
In the registry since
2006
Specialties on file
4

Practice location Address checks out

345 E 37th St Rm 319
New York, NY 10016-3256
Phone: (516) 385-1892
Show map & directions

Pin is approximate — placed at the ZIP-code centre, not the exact door.

Specialties & licences

Pediatric Pulmonology Physician (primary) Taxonomy 2080P0214X · Licence 002030 (NY)
Sleep Medicine (Internal Medicine) Physician Taxonomy 207RS0012X · Licence 249523 (NY)
Pediatric Critical Care Medicine Physician Taxonomy 2080P0203X · Licence 002030 (NY)
Pediatric Sleep Medicine Physician Taxonomy 2080S0012X · Licence 249523 (NY)

Record details

NPI number1356403042
Entity typeIndividual (Type 1)
GenderMale
Sole proprietorNo
NPI enumeratedDecember 16, 2006
Last updated in NPPESSeptember 4, 2024
Certification dateSeptember 4, 2024

Medicare enrollment

From the CMS Doctors & Clinicians file — this clinician is enrolled in Medicare.

Medicare specialtyPULMONARY DISEASE
Also practisesCRITICAL CARE (INTENSIVISTS)
Medical schoolOTHER
Graduated 1995 (31 years in practice)
Accepts Medicare assignment Yes — accepts the Medicare-approved amount

Medicare patients and services, 2024

From the CMS Medicare Physician & Other Practitioners file for calendar year 2024. It counts Original Medicare patients only, so a practice that mostly sees Medicare Advantage or privately insured patients looks smaller here than it is.

Medicare patients41
Services billed 171 a service is one billed item, such as a visit, a test or a procedure
Average patient age69

Dollar amounts are not shown. What Medicare pays a practice is gross billings, before staff, premises and tax and including the cost of any drugs it administers, so it is not what a clinician earns.

Payments from drug and device companies, 2025

Drug and device makers are required by federal law (the Physician Payments Sunshine Act) to report what they pay or give to clinicians, and CMS publishes the reports as Open Payments. This is the 2025 program year. A report is a record of a payment, not an allegation of anything, and many are small items such as meals. Only general payments are listed here; research payments and ownership or investment interests are reported separately by CMS and are not shown.

Food and Beverage $347 18 payments · a meal or drink at a meeting or visit, not a fee

Each amount is the sum of what companies reported for that kind of payment in 2025, rounded to the dollar. Not all of it is income to the clinician: a meal is not a fee, a charitable contribution goes to a charity, and a royalty or an acquisition payment is not a salary.

Check a report, or dispute one, at the source in CMS’s own tool, Open Payments. Corrections go through CMS’s dispute process. This site removes a home address on request and asks for no proof, because that is privacy; it will not remove an accurate payment report on request, because that is a statutory public disclosure.

Other providers in New York